Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA product code LTJ · Class 2 · 8 devices · 52 reports · 0 devices named in recalls
- Atellica IM PSA 10995662Siemens Healthcare Diagnostics Inc. · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS19 reports
- ADVIA Centaur® PSA 10310292Siemens Healthcare Diagnostics Inc. · Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers9 reports
- Atellica IM PSA 10995663Siemens Healthcare Diagnostics Inc. · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS9 reports
- ADVIA Centaur® PSA 10310293Siemens Healthcare Diagnostics Inc. · Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers5 reports
- VITROS 6801756Ortho Clinical Diagnostics · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS5 reports
- ARCHITECT 6C06-27Abbott Ireland Diagnostics · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS2 reports
- Elecsys free PSA 09744908190Roche Diagnostics GmbH · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS2 reports
- VITROS 1933027Ortho Clinical Diagnostics · PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS1 report